THE VANISHING SPECTRE of the pandemic has left in its wake contrasting shadows in different segments of the healthcare space. While hospitals showed strong recovery due to a rise in patient footfalls and surgeries, diagnostics companies’ revenues tanked following declining Covid-19 testing in the past two quarters. And while major pharmaceutical companies are seeing revenues recover, their ranks in the BT500—based on average market capitalisation from October 2021 to September 2022—have mostly fallen below 2021.
For instance, Sun Pharmaceutical Industries, India’s largest pharma company, saw its rank slip to 27 this year from 24 in 2021. But its consolidated Q4FY22 revenues grew 10.9 per cent year-on-year (YoY) to ₹9,386 crore. And in Q2FY23, the company recorded double-digit top line growth and strong margins driven by market share gain in India and sustained ramp-up of its global specialty business that grew 27.5 per cent. “We continue to focus on expanding our global specialty business and growing all our businesses,” Dilip Shanghvi, MD of Sun Pharma, told BT in an emailed response.
Similarly, Dr. Reddy’s Laboratories’ rank in the BT500 fell from 52 in 2021 to 70 in 2022, despite its strong performance in the past several quarters. In Q2FY23, it reported revenue growth of 11 per cent YoY.
Diese Geschichte stammt aus der December 11, 2022-Ausgabe von Business Today India.
Starten Sie Ihre 7-tägige kostenlose Testversion von Magzter GOLD, um auf Tausende kuratierte Premium-Storys sowie über 8.000 Zeitschriften und Zeitungen zuzugreifen.
Bereits Abonnent ? Anmelden
Diese Geschichte stammt aus der December 11, 2022-Ausgabe von Business Today India.
Starten Sie Ihre 7-tägige kostenlose Testversion von Magzter GOLD, um auf Tausende kuratierte Premium-Storys sowie über 8.000 Zeitschriften und Zeitungen zuzugreifen.
Bereits Abonnent? Anmelden
Pension Scheme - Safety Net
The move to introduce the UPS has evoked mixed reactions. Analysts believe its funding will have limited impact on the fiscal math
The Reit Choice?
Real Estate Investment Trusts (Reits) Are Gaining Traction As Interest Rates Stabilise. But Returns Could Be Affected By Adverse Economic Conditions And Market Volatility
CORPORATE - Calling to Account
The sudden exit of Byju's auditor BDO marks the latest in a long series of setbacks for the edtech firm
EMPLOYMENT: Skills Push
The skill development ministry plans to partner with the UGC to improve the employability of undergraduates
Building on a Vision
L&T'S CHAIRMAN EMERITUS A. M. NAIK HAS BUILT A MAMMOTH ENTERPRISE THAT IS BUILDING A NEW INDIA, FROM ITS METRO RAIL SYSTEMS TO THE RAM TEMPLE
"KYS more important than KYC"
Vijay Kedia is a renowned equity investor; the value of his listed portfolio stands at around ₹1,750 crore
ROXX STAR
THE THAR ROXX COMBINES LUXURY WITH PERFORMANCE TO MAKE A STRONG STATEMENT IN THE MID-SIZE SUV SEGMENT
HIT THE GROUND RUNNING
Smartwatches have become indispensable tools for runners, offering real-time insights into pace, distance, heart rate, and more. Here are a few you can consider
TURNING THE TABLES
INDIA'S FURNITURE MARKET IS POISED FOR A GLOBAL TAKE-OFF. ALREADY, A HOST OF GLOBAL BRANDS HAVE MADE THE COUNTRY THEIR HOME, BUT INDIAN COMPANIES ARE NOT TOO FAR BEHIND
THE EVOLUTION OF ATHERA
IDENTIFYING OPPORTUNITIES IN ADVANCE HAS STOOD THIS BENGALURU-BASED VC FUND IN GOOD STEAD. NOW, WITH A HEIGHTENED FOCUS ON TECHNOLOGY, IT WANTS TO SUSTAIN THE SUCCESS